App-based contingency management to reduce heavy drinking days among smokers receiving varenicline: Feasibility, acceptability, and efficacy indicators from a phase I analog trial.
Year: 2026
Type: article
Abstract: < .01). The combination of VC and app-based CM was shown to be feasible and well accepted, with an initial signal of efficacy to reduce heavy-drinking and cigarette smoking. This combined therapeutic may provide a novel approach to treat tobacco smoking and AUD concomitantly. (PsycInfo Database Record (c) 2026 APA, all rights reserved).
DOI: 10.1037/pha0000790
Institution: Washington State University
Language: English
Subfield: Physiology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Funder: National Institutes of Health
OpenAlex ID: W7165126739